These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Effect of highly purified eicosapentaenoic acid on psoriasis. Kojima T, Terano T, Tanabe E, Okamoto S, Tamura Y, Yoshida S. J Am Acad Dermatol; 1989 Jul; 21(1):150-1. PubMed ID: 2545748 [No Abstract] [Full Text] [Related]
47. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC, Meier KE, Henderson WR. J Immunol; 1987 May 15; 138(10):3396-402. PubMed ID: 3033073 [Abstract] [Full Text] [Related]
48. The effect of highly purified eicosapentaenoic acid in patients with psoriasis. Terano T, Kojima T, Seya A, Tanabe E, Hirai A, Makuta H, Ozawa A, Fujita T, Tamura Y, Okamoto S. Adv Prostaglandin Thromboxane Leukot Res; 1989 May 15; 19():610-3. PubMed ID: 2546400 [No Abstract] [Full Text] [Related]
52. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC, Meier KE, Henderson WR. J Immunol; 1987 May 15; 138(10):3396-402. PubMed ID: 3033073 [Abstract] [Full Text] [Related]
53. The effect of highly purified eicosapentaenoic acid in patients with psoriasis. Terano T, Kojima T, Seya A, Tanabe E, Hirai A, Makuta H, Ozawa A, Fujita T, Tamura Y, Okamoto S. Adv Prostaglandin Thromboxane Leukot Res; 1989 May 15; 19():610-3. PubMed ID: 2546400 [No Abstract] [Full Text] [Related]
54. [Potential value of eicosapentaenoic acid]. Robin JL. Allerg Immunol (Paris); 1987 Oct 15; 19(8 Suppl):12-3. PubMed ID: 2839201 [Abstract] [Full Text] [Related]
55. 5-Lipoxygenase activation in psoriasis: a dead issue? Ford-Hutchinson AW. Skin Pharmacol; 1993 Oct 15; 6(4):292-7. PubMed ID: 8198815 [Abstract] [Full Text] [Related]
57. The effect of highly purified eicosapentaenoic acid in patients with psoriasis. Terano T, Kojima T, Seya A, Tanabe E, Hirai A, Makuta H, Ozawa A, Fujita T, Tamura Y, Okamoto S. Adv Prostaglandin Thromboxane Leukot Res; 1989 Oct 15; 19():610-3. PubMed ID: 2546400 [No Abstract] [Full Text] [Related]
59. 5-Lipoxygenase activation in psoriasis: a dead issue? Ford-Hutchinson AW. Skin Pharmacol; 1993 Oct 15; 6(4):292-7. PubMed ID: 8198815 [Abstract] [Full Text] [Related]
60. Substrate and regulatory functions of eicosapentaenoic and docosahexaenoic acids for the 5-lipoxygenase pathway. Implications for pulmonary responses. Lee TH, Drazen JM, Lewis RA, Austen KF. Prog Biochem Pharmacol; 1985 Oct 15; 20():1-17. PubMed ID: 2581266 [No Abstract] [Full Text] [Related] Page: [Previous] [New Search]